Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-29

Clinical Trial Update: Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial investigating ascorbic acid, corticosteroids, and thiamine (ACTS) in sepsis and septic shock; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ascorbic acid (Vitamin C)
  • Corticosteroids (corticosteroids)
  • Thiamine (thiamine)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Sepsis, Septic Shock | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-01-29